XML 33 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Research and development expenses, net $ 8,311
General and administrative expenses 2,373 9,462 9,550
Impairment of fixed assets 1,426
Operating income (loss) (2,373) (9,462) (19,287)
Other income (expense):      
Impairment of loans receivable (16,487)
Income on Debt Extinguishment and Conversion 6,525
Finance income, net (12) 800 1,719
Net income (loss) 4,140 (25,149) (17,568)
Comprehensive income (loss) $ 4,140 $ (25,149) $ (17,568)
Income (loss) per share:      
Net income (loss) per ordinary share - basic (in Dollars per share) $ 0.66 $ (4.3) $ (3)
Net income (loss) per ordinary share - diluted (in Dollars per share) $ 0.66 $ (4.3) $ (3)
Weighted average number of ordinary shares outstanding - basic (in Shares) 6,232,226 5,849,013 5,848,737
Weighted average number of ordinary shares outstanding - diluted (in Shares) 6,232,226 5,849,013 5,848,737